PharmaResources (Shanghai) Co., Ltd. (SHE:301230)
China
· Delayed Price · Currency is CNY 41.95
+0.35 (0.84%)
At close: Apr 29, 2026
SHE:301230 Market Cap
SHE:301230 has a market cap or net worth of 5.77 billion as of April 29, 2026. Its market cap has increased by 30.64% in one year.
Market Cap
5.77B
Enterprise Value
5.64B
Revenue
691.21M
Ranking
n/a
PE Ratio
131.59
Stock Price
41.95
Market Cap Chart
Since November 1, 2022, SHE:301230's market cap has increased from 3.94B to 5.77B, an increase of 46.51%. That is a compound annual growth rate of 11.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 5.77B | 40.44% |
| Dec 31, 2025 | 4.11B | 17.05% |
| Dec 31, 2024 | 3.51B | -8.90% |
| Dec 29, 2023 | 3.85B | -6.18% |
| Dec 30, 2022 | 4.11B | 4.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novogene | 5.90B |
| Shenzhen Weiguang Biological Products | 5.88B |
| Lifecome Biochemistry | 5.96B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.79B |
| Kexing Biopharm | 5.70B |
| Wuhan Hvsen Biotechnology | 5.70B |
| Beijing Konruns Pharmaceutical | 5.69B |
| Innovita Biological Technology | 6.20B |